PER percheron therapeutics limited
Add to My Watchlist 0.00% ! 0.9¢

Where others have failed will Atl1102 succeed ?

  1. itsagas
    14,959 Posts.
    lightbulb Created with Sketch. 1619
    clock Created with Sketch.
    17/05/21
    15:54
    Post #: 53226743
    Ionis and others have failed to tackle Alzheimer’s and Parkinson’s and other Neurodegenerative disorders. Will Atl1102 be the blockbuster drug to succeed.
    https://hotcopper.com.au/data/attachments/3186/3186880-959aedaf7b16fcc2ae3ec02d6b8eeeb7.jpg
    ANP Price at posting: 17.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $9.786M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
6 3002362 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 3823828 9
View Market Depth
Last trade - 16.21pm 16/09/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.